Anbarasan Sekar

Mumbai, MH 400094, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Patient derived xenograft models of hormone receptor positive and HER2 negative breast cancer from Indian patients.

Patient derived xenograft models of hormone receptor positive and HER2 negative breast cancer from Indian patients.

Journal: Scientific reports

Published: April 26, 2025

Retrospective Study to Determine Factors Influencing Outcome in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy.

Retrospective Study to Determine Factors Influencing Outcome in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy.

Journal: JCO global oncology

Published: April 23, 2025

Combination chemotherapy and hormone therapy in patients with hormone receptor positive and HER2 negative metastatic breast cancer.

Combination chemotherapy and hormone therapy in patients with hormone receptor positive and HER2 negative metastatic breast cancer.

Journal: Scientific reports

Published: March 25, 2025

Clinical profile and outcomes of young women with denovo-metastatic breast cancer: real-world data from a tertiary care centre in India.

Clinical profile and outcomes of young women with denovo-metastatic breast cancer: real-world data from a tertiary care centre in India.

Journal: Ecancermedicalscience

Published: November 17, 2024

Correction: Epidemiological Trend of Esophageal Cancer at a Tertiary Cancer Center in Mumbai, India, over the Past 15 Years.

Correction: Epidemiological Trend of Esophageal Cancer at a Tertiary Cancer Center in Mumbai, India, over the Past 15 Years.

Journal: Journal of gastrointestinal cancer

Published: July 17, 2024

Predictive significance of inflammatory markers in the survival of older Indian patients with cancer: a single-center prospective analysis.

Predictive significance of inflammatory markers in the survival of older Indian patients with cancer: a single-center prospective analysis.

Journal: Ecancermedicalscience

Published: May 15, 2024

Adjuvant therapy may improve overall survival in high-risk periampullary adenocarcinomas patients - A match-pair analysis from a multi-institutional cohort study (The MIPPAP study).

Adjuvant therapy may improve overall survival in high-risk periampullary adenocarcinomas patients - A match-pair analysis from a multi-institutional cohort study (The MIPPAP study).

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: December 27, 2023

Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial.

Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial.

Journal: The Lancet. Oncology

Published: October 24, 2023

Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer.

Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 09, 2023

Practice Patterns and Survival in Patients with Resected Pancreatic Ductal Adenocarcinomas (PDAC) - Results from the Multicentre Indian Pancreatic & Periampullary Adenocarcinoma Project (MIPPAP) Study.

Practice Patterns and Survival in Patients with Resected Pancreatic Ductal Adenocarcinomas (PDAC) - Results from the Multicentre Indian Pancreatic & Periampullary Adenocarcinoma Project (MIPPAP) Study.

Journal: Journal of gastrointestinal cancer

Published: April 03, 2023

Epidemiological Trend of Esophageal Cancer at a Tertiary Cancer Center in Mumbai, India, Over the Past 15 Years.

Epidemiological Trend of Esophageal Cancer at a Tertiary Cancer Center in Mumbai, India, Over the Past 15 Years.

Journal: Journal of gastrointestinal cancer

Published: November 13, 2022

Outcomes of non-metastatic triple negative breast cancers: Real-world data from a large Indian cohort.

Outcomes of non-metastatic triple negative breast cancers: Real-world data from a large Indian cohort.

Journal: Breast (Edinburgh, Scotland)

Published: February 15, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026